Trial Profile
Effect of strontium ranelate on bone mineral density and bone turnover markers
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Apr 2014
Price :
$35
*
At a glance
- Drugs Strontium ranelate (Primary)
- Indications Postmenopausal osteoporosis
- Focus Pharmacodynamics; Therapeutic Use
- 22 Apr 2014 New trial record